The Recombinant Proteins Global Market Report 2023, provides comprehensive information on the recombinant proteins market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Recombinant Proteins Market’s Growth:
https://www.thebusinessresearchcompany.com/report/recombinant-proteins-global-market-report
The global recombinant proteins market size is expected to grow from $1.91 billion in 2022 to $2.12 billion in 2023 at a compound annual growth rate (CAGR) of 11.29%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global recombinant proteins market size is expected to reach $3.35 billion in 2027 at a CAGR of 12.10%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=9959&type=smp
Product innovation is the key trend gaining popularity in the recombinant protein market. Major companies operating in the recombinant protein market are focused on developing innovative products to strengthen their position in the market. For instance, in May 2020, Teva and Celltrion Healthcare, a US-based manufacturer of drugs, launched an injection called TRUXIMA, which is a biosimilar to the reference medicine Rituxan®1 (rituximab) on the market for the treatment of rheumatoid arthritis, with a boxed warning for fatal infusion-related complications, severe mucocutaneous reactions, hepatitis B virus reactivation, and progressive multifocal leukoencephalopathy. The unique feature about this product is its ability to treat various disorders such as Non-Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), and Microscopic Polyangiitis (MPA).
The recombinant proteins market is segmented:
1) By Product: Antibodies, Cytokines, Immune Checkpoint Protein, Virus Antigens, Enzymes, Recombinant Regulatory Proteins, Hormones, Other Products
2) By Application: Drug And Discovery Development, Therapeutics, Research, Other Applications
3) By End Users: Pharmaceutical And Biotechnology Companies, Academic And Research Institute, Diagnostic Laboratories, Other End Users
North America was the largest region in the recombinant proteins market in 2022.
The table of contents in TBRC’s recombinant proteins market report includes:
- Executive Summary
- Recombinant Proteins Market Characteristics
- Recombinant Proteins Market Trends And Strategies
- Recombinant Proteins Market – Macro Economic Scenario
- Recombinant Proteins Market Size And Growth
.
.
.
- Africa Recombinant Proteins Market
- Recombinant Proteins Market Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions In The Recombinant Proteins Market
- Recombinant Proteins Market Future Outlook and Potential Analysis
- Appendix
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
